Jm. Monti et al., THE SELECTIVE HISTAMINE H-1-RECEPTOR AGONIST 2-(3-TRIFLUOROMETHYLPHENYL)HISTAMINE INCREASES WAKING IN THE RAT, European neuropsychopharmacology, 4(4), 1994, pp. 459-462
The effects of the selective histamine H-1-receptor agonist, 2-(3-trif
luoromethylphenyl)histamine, were studied in rats implanted with elect
rodes for chronic sleep recordings. 2-(3-Trifluoromethylphenyl)histami
ne (80-120 mu g) injected into the left lateral ventricle increased wa
kefulness, whereas slow wave sleep was reduced. Pretreatment with pyri
lamine (2.0 mg/kg) prevented the effects of the H-1-receptor agonist o
n wakefulness and slow wave sleep. Our results further support the inv
olvement of histamine in the modulation of the waking state.